1. Market Research
  2. > Biotechnology Market Trends
  3. > Biotechnology Analysis & Statistics in the United States, August 2018 (p40)

Biotechnology Analysis & Statistics in the United States, August 2018 (p40)

Customer Support

Talk to Ahmad

+1 718 618 4302

Publishers

All regions

1171-1200 of about 3200 reports

Osteogenesis Imperfecta - Pipeline Review, H2 2018

Osteogenesis Imperfecta - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Osteogenesis Imperfecta - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Osteogenesis Imperfecta - Pipeline Review, H2 2018, provides ...

  • Industries : Therapy, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Pathology
  • Countries : United States, World
Twist Bioscience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Twist Bioscience Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2018

SummaryTwist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process.The company provides products includes DNA pools for gRNA ...

  • Industries : Genomics Proteomics and Enabling Technology
  • Countries : United States
Inivata Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Inivata Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2018

SummaryInivata Ltd (Inivata) is a cancer genomics company.The company offers products such as invisionfirst- lungin and visionseq.Its InVisionFirst offers advanced sequencing technology to detect single ...

  • Industries : Healthcare, Genomics Proteomics and Enabling Technology
  • Countries : United Kingdom, United States, World
Next-Generation Sequencing Market by Product, Consumables, Bioinformatics, Services, Technology, Application, End User - Global Forecasts to 2024

Next-Generation Sequencing Market by Product, Consumables, Bioinformatics, Services, Technology, Application, End User - Global Forecasts to 2024

  • $ 5650
  • Industry report
  • August 2018

Global Next-generation Sequencing Market to Register a CAGR of 19.2% from 2018 to 2024The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024 from USD 5.70 billion ...

  • Industries : Diagnostics, Healthcare, Biotechnology, Genomics Proteomics and Enabling Technology
  • Countries : United States, North America
Sernova Corp (SVA) - Product Pipeline Analysis, 2018 Update

Sernova Corp (SVA) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummarySernova Corp (Sernova) is a clinical stage regenerative medicines company which develops and commercializes medical device and combination products for the treatment of chronic diseases.The company ...

  • Industries : Medical Biotechnology, Pathology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

Natera Inc (NTRA) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummaryNatera Inc (Natera), formerly Gene Security Network Inc is a genetic testing and diagnostics company that develops and commercializes non-invasive methods for DNA analysis.The company offers products ...

  • Industries : Diagnostics, Medical Biotechnology, Cancer, Biotechnology
  • Countries : United States
Marina Biotech Inc (MRNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Marina Biotech Inc (MRNA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2018

SummaryMarina Biotech Inc (Marina) is a nucleic acid-based drug discovery and development company that focuses on rare diseases.It focuses on treating the intersection of arthritis, hypertension, pain, ...

  • Industries : Therapy, Biotechnology, Pharmaceutical
  • Countries : United States
Grass Pollen Allergy - Pipeline Review, H2 2018

Grass Pollen Allergy - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Grass Pollen Allergy - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Grass Pollen Allergy - Pipeline Review, H2 2018, provides an ...

  • Industries : Chronic Disease, Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States
Bronchopulmonary Dysplasia - Pipeline Review, H2 2018

Bronchopulmonary Dysplasia - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Bronchopulmonary Dysplasia - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bronchopulmonary Dysplasia - Pipeline Review, H2 2018, ...

  • Industries : Therapy, Medical Biotechnology, Pharmaceutical
  • Countries : United States
Periodontitis - Pipeline Review, H2 2018

Periodontitis - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Periodontitis - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Periodontitis - Pipeline Review, H2 2018, provides an overview of the ...

  • Industries : Pathology
  • Countries : United States
Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2018

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Alpha- Antitrypsin Deficiency - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Alpha- Antitrypsin Deficiency - Pipeline Review, H2 ...

  • Industries : Pharmaceutical, Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Diabetic Nephropathy - Pipeline Review, H2 2018

Diabetic Nephropathy - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Diabetic Nephropathy - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Diabetic Nephropathy - Pipeline Review, H2 2018, provides an ...

  • Industries : Chronic Disease, Pathology, Pharmaceutical, Therapy
  • Countries : United States
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Idiopathic ...

  • Industries : Pathology, Healthcare
  • Countries : United States
Primary Immune Deficiency (PID) - Pipeline Review, H2 2018

Primary Immune Deficiency (PID) - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Primary Immune Deficiency (PID) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Primary Immune Deficiency (PID) - Pipeline Review, ...

  • Industries : Pathology, Medical Biotechnology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical, Therapy, Healthcare
  • Countries : United States
Duchenne Muscular Dystrophy - Pipeline Review, H2 2018

Duchenne Muscular Dystrophy - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Duchenne Muscular Dystrophy - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Duchenne Muscular Dystrophy - Pipeline Review, H2 2018, ...

  • Industries : Pathology, Mental Health, Pharmaceutical, Therapy
  • Countries : United States
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2018

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • August 2018

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) - Pipeline Review, H2 2018SummaryNon Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) pipeline Target constitutes close to 18 ...

  • Industries : Pathology, Cancer, Medical Biotechnology, Pharmaceutical
  • Countries : United States, World
Cyclin Dependent Kinase 7 - Pipeline Review, H2 2018

Cyclin Dependent Kinase 7 - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • August 2018

Cyclin Dependent Kinase 7 (39 kDa Protein Kinase or CDK Activating Kinase 1 or Cell Division Protein Kinase 7 or TFIIH Basal Transcription Factor Complex Kinase Subunit or Serine/Threonine Protein Kinase ...

  • Industries : Cancer, Pathology, Therapy, Pharmaceutical
  • Countries : United States
Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2018

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal Polyposis) - Pipeline Review, H2 ...

  • Industries : Therapy, Chronic Disease, Pathology, Medical Biotechnology, Pharmaceutical
  • Countries : United States
Global Immortalized Cell Line Market Research Report - Forecast to 2023

Global Immortalized Cell Line Market Research Report - Forecast to 2023

  • $ 4450
  • Industry report
  • August 2018

IntroductionImmortalized cell lines are either tumorous cells that do not stop dividing or cells that have been artificially manipulated to proliferate indefinitely and can, thus, be cultured over several ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical
  • Countries : World, United States, North America
Ragweed Pollen Allergy - Pipeline Review, H2 2018

Ragweed Pollen Allergy - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Ragweed Pollen Allergy - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Ragweed Pollen Allergy - Pipeline Review, H2 2018, provides ...

  • Industries : Chronic Disease, Medical Biotechnology, Pathology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, World
Thalassemia - Pipeline Review, H2 2018

Thalassemia - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Thalassemia - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Thalassemia - Pipeline Review, H2 2018, provides an overview of the Thalassemia ...

  • Industries : Pathology, Pharmaceutical, Healthcare, Therapy
  • Countries : United States
Glutamate Carboxypeptidase 2 - Pipeline Review, H2 2018

Glutamate Carboxypeptidase 2 - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • August 2018

Glutamate Carboxypeptidase 2 (Folate Hydrolase 1 or Prostate Specific Membrane Antigen or PSMA or Pteroylpoly Gamma Glutamate Carboxypeptidase or Cell Growth Inhibiting Gene 27 Protein or FOLH1 or EC 3.4.17.21) ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Therapy, Pharmaceutical
  • Countries : United States
Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline Review, H2 2018

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Granulomatosis with Polyangiitis (Wegener’s Granulomatosis) - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Granulomatosis with ...

  • Industries : Medical Biotechnology, Therapy, Pathology, Pharmaceutical, Biopharmaceutical, Biopharmaceutical
  • Countries : United States
Bone Marrow Transplant Rejection - Pipeline Review, H2 2018

Bone Marrow Transplant Rejection - Pipeline Review, H2 2018

  • $ 2000
  • Company report
  • August 2018

Bone Marrow Transplant Rejection - Pipeline Review, H2 2018SummaryGlobal Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Bone Marrow Transplant Rejection - Pipeline Review, ...

  • Industries : Healthcare, General Medicine and Specialty Medicine, Health Services, Pharmaceutical, Therapy, Medical Biotechnology
  • Countries : United States
Datamonitor Healthcare Ulcerative Colitis KOL Interviews

Datamonitor Healthcare Ulcerative Colitis KOL Interviews

  • $ 599
  • Industry report
  • August 2018

OverviewDatamonitor Healthcare interviewed two ulcerative colitis (UC) experts, one based in Italy and the other in the US, to gauge their views on approved and late-stage pipeline drugs, treatment challenges ...

  • Industries : Medical Biotechnology, Therapy, Biopharmaceutical, Biopharmaceutical, Oncology
  • Countries : Italy, United States
Leukapheresis Market by Product, Leukopak, Application, End User - Global Forecast to 2023

Leukapheresis Market by Product, Leukopak, Application, End User - Global Forecast to 2023

  • $ 5650
  • Industry report
  • August 2018

The leukapheresis products and leukopaks markets are projected to grow at a CAGR of 7.4% and 46.4%, respectively.The leukapheresis products market is expected to reach USD 27.7 million by 2023 from an ...

  • Industries : Healthcare
  • Countries : United States, North America
Biocept Inc (BIOC) - Product Pipeline Analysis, 2018 Update

Biocept Inc (BIOC) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummaryBiocept Inc (Biocept) is a molecular diagnostics company.The company develops and commercializes proprietary circulating tumor cell (CTC) and circulating tumor DNA assays utilizing a standard blood ...

  • Industries : Diagnostics, Medical Biotechnology, Cancer
  • Countries : United States
Quanterix Corp (QTRX) - Product Pipeline Analysis, 2018 Update

Quanterix Corp (QTRX) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummaryQuanterix Corp (Quanterix) is a medical equipment provider that offers proteins measurement solutions.The company’s products include biomarker detection system, assay kits, single molecule detecto ...

  • Industries : Pathology, Diagnostics, Healthcare
  • Countries : United States
Access Bio Inc (950130) - Product Pipeline Analysis, 2018 Update

Access Bio Inc (950130) - Product Pipeline Analysis, 2018 Update

  • $ 750
  • Company report
  • August 2018

SummaryAccess Bio Inc (Access Bio) is a medical device company that research, develops, manufactures and markets in-vitro diagnostics tests, biosensor, and molecular diagnostic products.The company provides ...

  • Industries : Diagnostics
  • Countries : United States
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2018

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2018

  • $ 3500
  • Company report
  • August 2018

Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin Binding Growth Factor 2 or FGF2) - Pipeline Review, H2 2018SummaryFibroblast Growth Factor 2 (Basic Fibroblast Growth Factor or Heparin ...

  • Industries : Pharmaceutical, Therapy, Health Services
  • Countries : United States, World

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on